代谢控制分析使得使用大肠杆菌 (Escherichia coli) 改善了L-氨酸的生产过程
Daniel Alejandro Caballero Cerbon1, Jeremias Widmann1, Dirk Weuster-Botz2
1Chair of Biochemical Engineering, School of Engineering and Design, Technical University of Munich, Boltzmannstr. 15, 85748, Garching, Germany.
Applied microbiology and biotechnology
|January 12, 2024
概括
代谢控制分析显示,O-乙胺 (OAS) 出口限制了工程化大肠杆菌中的L-氨酸生产. 过度表达L-氨酸合成酶显著提高了L-氨酸的生产力和发酵过程中的产量.
科学领域:
- 生物技术是生物技术.
- 代谢工程是代谢工程.
- 微生物发酵 微生物发酵
背景情况:
- 化学L-氨酸生产对环境产生了重大影响.
- 使用工程Escherichia coli (E. coli) 的发酵生产提供了一个可持续的替代方案.
- 现有的发酵过程往往遭受低产量,需要进一步优化.
研究的目的:
- 为了确定限制工程化大肠杆菌L-氨酸生产的代谢瓶.
- 通过有针对性的代谢工程来提高L-氨酸的产量和生产力.
- 调查O-乙氨酸 (OAS) 代谢在L-氨酸生物合成中的作用.
主要方法:
- 在体内代谢控制分析 (MCA) 使用扰乱实验.
- 通过液态染色体质谱法 (LC-MS) 进行代谢学分析.
- 热力学流量分析 (TFA) 来评估代谢途径的效率.
主要成果:
- MCA表示,O-乙胺 (OAS) 的出口超过了其转化为L-氨酸.
- 增加L-氨酸合成酶 (硫氨酸合成酶或L-氨酸合成酶) 的表达提高了生产力.
- 特定L-氨酸的生产率增加了高达70%,最终度增加了高达47%.
结论:
- 在大肠杆菌的L-氨酸酶发酵中,OAS出口的速度是一个关键的限制因素.
- 过度表达关键的L-氨酸生物合成酶可以增强L-氨酸的产生.
- 这种代谢工程策略显著改善了葡萄糖产量和整体工艺效率.
更多相关视频
相关概念视频
Bioreactor Controls-III
Strain improvement is a foundational strategy in industrial microbiology aimed at maximizing microbial productivity, particularly because natural isolates typically yield commercially valuable products in very low concentrations. Although optimizing the culture medium and environmental conditions can improve yields, these adjustments are inherently limited by the organism’s genetic potential. As a result, the focus shifts toward genetic modifications to enhance biosynthetic capacity. The...
Upstream Processing
Upstream processing represents a critical phase in biomanufacturing, wherein biological systems such as microorganisms, mammalian cells, or insect cells are cultivated to produce therapeutic proteins, vaccines, enzymes, or other biologically derived products. This phase encompasses all steps from the selection and genetic manipulation of the production organism to the cultivation of cells in bioreactors under tightly controlled environmental conditions.Host Selection and Genetic OptimizationThe...
Production of Antibiotics
Penicillin, one of the earliest and most widely used antibiotics, is produced industrially by the filamentous fungus Penicillium chrysogenum. Large stirred-tank bioreactors ranging from tens to hundreds of thousands of liters maintain tightly controlled temperature, pH, and dissolved oxygen conditions to support fungal metabolism and maximize antibiotic yield. Penicillin is a secondary metabolite, synthesized primarily during the stationary growth phase, which requires a carefully managed...
Production of Pharmaceuticals
Industrial insulin production uses genetically engineered E. coli expressing a proinsulin gene controlled by a tryptophan promoter and containing a methionine linker for later cleavage. The cells also carry ampicillin resistance for selective growth. Seed cultures are stored at −80 °C and production begins by thawing a small amount to inoculate starter cultures, which are progressively scaled to a 50,000-L bioreactor. In the bioreactor, E. coli grow in nutrient-rich media under sterile, tightly...


